글로벌 비뇨생식기 약물 시장 – 2028년까지의 산업 동향 및 예측

비뇨생식기 약물 시장의 시장 분석 및 통찰력                                                                                                               

비뇨생식기 약물 시장은 2021년에서 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 2028년까지 시장이 422억 4천만 달러에 이를 것으로 분석하고, 위에 언급된 예측 기간 동안 1.83%의 CAGR로 성장할 것이라고 예측했습니다.

비뇨생식기 약물은 신장, 방광, 요도 및 요관과 관련된 다양한 암을 치료하는 데 널리 사용됩니다. 다양한 스테로이드와 면역 억제제가 접근 가능하여 관련 지표의 치료에서 부작용이 발생합니다. 

비뇨생식기 질환의 유병률 증가는 비뇨생식기 약물 시장의 성장과 수요를 강화하는 중요한 요인 중 하나입니다. 또한, 파이프라인 약물 의 증가 , 기술 발전, 암 유병률 증가 도 2021년에서 2028년까지의 예측 기간 동안 글로벌 시장 성장에 기여하고 있습니다. 또한 주로 도시 인구의 가처분 소득 증가와 효과적인 약물의 높은 채택도 시장 성장을 강화하고 있습니다. 마찬가지로, R&D 지출 증가와 라이선싱 및 계약과 같은 최고 시장 참여자가 채택한 협력 전략도 위에 언급된 예측 기간 동안 시장 성장을 촉진하고 있습니다. 개별 정부가 의료 인프라를 개선하기 위해 많은 투자를 하고 요실금과 기술 발전에 대한 우려가 커지면서 비뇨생식기 약물 시장이 더욱 확대될 것이며 2021년에서 2028년까지의 예측 기간 동안 시장에 상당한 성장 기회를 제공하고 있습니다.

However, the continual patent expirations, increasing generics drug competition and increasing advent of counterfeit drugs will curb the growth of the genitourinary drugs market, whereas the lack of compliance to medication has the potential to challenge the growth of the genitourinary drugs market.

This genitourinary drugs market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on genitourinary drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Genitourinary Drugs Market Scope and Market Size

Genitourinary drugs market is segmented on the basis of indication and drug type. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of indication, the genitourinary drugs market is segmented into prostate cancer, ovarian cancer, bladder cancer, cervical cancer, renal cancer, erectile dysfunction, urinary tract infections, urinary incontinence and overactive bladder, sexually transmitted diseases, interstitial cystitis, hematuria and benign prostatic hyperplasia.
• The drug type segment of genitourinary drugs market is segmented into hormonal therapy, impotence agents, uterine relaxants, urinary antispasmodics, urinary PH modifiers, uterine stimulants, miscellaneous genitourinary and tract agents.

Genitourinary Drugs Market Country Level Analysis

Genitourinary drugs market is analyzed and market size insights and trends are provided by country, product type and end user as referenced above.

The countries covered in the genitourinary drugs market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America region leads the genitourinary drugs market owing to the increasing prevalence of major genitourinary diseases as well as the surging demand for the therapeutics within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rapid high R&D investment deployed by the global players and the increase in disposable income within this particular region.

The country section of the genitourinary drugs market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Genitourinary drugs market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for genitourinary drugs market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the genitourinary drugs market. The data is available for historic period 2011 to 2019.

Competitive Landscape and Genitourinary Drugs Market Share Analysis

Genitourinary drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to genitourinary drugs market.

비뇨생식기 약물 시장 보고서에서 다루는 주요 기업으로는 Pfizer Inc., Astellas Pharma US, Inc., Allergan, GlaxoSmithKline plc, Antares Pharma, Eli Lilly and Company, Bayer AG, Merck KGaA, Abbott, Bristol-Myers Squibb Company, Genentech USA, Inc., F. Hoffman-La Roche Ltd., Novartis AG, Teva Pharmaceutical Industries Ltd., AstraZeneca, Advanz Pharmaceutical 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-29922